Skip to main content

Together we are beating cancer

Donate now

Cancer News

Research and trials

Showing 12 out of 1699 results
A group of microscopic glioblastoma cells against a black background. The cells are coloured red, with their steroid receptors marked in green.

Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet. Our researchers have found that steroids, vital tools for managing brain tumour symptoms, could also make glioblastomas vulnerable to a special diet.

by Fiona MacLeod, Tim Gunn | Analysis | 20 February 2026

20 February 2026

A woman facing away from the camera looks at medicine on pharmacy shelves.

With our funding, researchers at Imperial College London are investigating whether we can look for patterns in the medicines people buy to identify very early-stage cancers. With our funding, researchers at Imperial College London are investigating whether we can look for patterns in the medicines people buy to identify very early-stage cancers.

by Tim Gunn | News | 2 February 2026

2 February 2026

A computer generated microscopic image of purple lung cancer cells with a genetic mutation.
  • Science & Technology
  • Health & Medicine

Our defining research stories of 2025

2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year. 2025 has been a huge year for research at Cancer Research UK. To celebrate, we've brought together our most defining research stories of the year.

by Amal Iman | In depth | 19 December 2025

19 December 2025

A patient and a GP having a discussion in the GP's office.

The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next. The UK NSC's proposed programme would invite 45 to 61-year-old men with BRCA mutations for prostate cancer screening every two years. Here's what it means and what will happen next.

by Cancer Research UK | Analysis | 28 November 2025

28 November 2025

2D image of scientist hands with a cancer vaccine vial and needle
  • Health & Medicine
  • Science & Technology

Cancer Vaccines - where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs, new partnerships and current clinical trials, could we be closer than ever?

by Sophie Wedekind | In depth | 20 November 2025

20 November 2025

A microscopic image of two lung cancer cells dividing, held together by a very thin bridge of cytoplasm.

With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine. With £2m in funding, our scientists will begin clinical trials to see if LungVax could be the world's first preventative lung cancer vaccine.

by Amal Iman | News | 17 November 2025

17 November 2025

A pill in a petri dish. The Pill is transparent but contains a compressed black sponge. There is a light blue thread attached to one end.
  • Health & Medicine
  • Science & Technology

Meet the capsule sponge

This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks. This sponge on a string could help stop oesophageal cancer – one of the hardest to treat cancers – in its tracks.

by Amal Iman | In depth | 13 November 2025

13 November 2025

A cluster of different sized pink cells seen through a microscope.

Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source. Our researchers discovered that EGFR, a molecule produced by our cells, can fuel cancer growth. This breakthrough led to the development of targeted treatments that attack cancer at its source.

by Henry Scowcroft | In depth | 13 November 2025

13 November 2025

Squamous epithelial cells of human cervix under the microscope view.
  • Health & Medicine
  • Science & Technology

70 years of progress in cervical cancer research

25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends. 25 years ago, our scientists showed that nearly all cervical cancers are caused by the human papillomavirus (HPV). But that’s not where our story with cervical cancer research starts, and it certainly isn’t where it ends.

by Jacob Smith | In depth | 13 November 2025

13 November 2025

A computer generated image showing two DNA helices in shades of blue.

A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients. A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients.

by Amal Iman | News | 7 August 2025

7 August 2025